232 related articles for article (PubMed ID: 387224)
1. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
[TBL] [Abstract][Full Text] [Related]
3. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
[TBL] [Abstract][Full Text] [Related]
4. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
[TBL] [Abstract][Full Text] [Related]
6. Cis-dichlorodiammine platinum (II) in advanced ovarian carcinoma.
Stewart JF; Tattersall MH; Woods RL; Fox RM
Med J Aust; 1979 Jun; 1(12):548-50. PubMed ID: 470725
[TBL] [Abstract][Full Text] [Related]
7. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.
Gralla RJ; Cvitkovic E; Golbey RB
Cancer Treat Rep; 1979; 63(9-10):1585-8. PubMed ID: 498158
[TBL] [Abstract][Full Text] [Related]
8. The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).
Vogl SE; Berenzweig M; Kaplan BH; Moukhtar M; Bulkin W
Cancer Treat Rep; 1979 Feb; 63(2):311-7. PubMed ID: 109202
[TBL] [Abstract][Full Text] [Related]
9. cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer.
Wittes R; Heller K; Randolph V; Howard J; Vallejo A; Farr H; Harrold C; Gerold F; Shah J; Spiro R; Strong E
Cancer Treat Rep; 1979; 63(9-10):1533-8. PubMed ID: 498153
[TBL] [Abstract][Full Text] [Related]
10. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
[No Abstract] [Full Text] [Related]
11. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.
Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R
Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
Kane R; Harvey H; Andrews T; Bernath A; Curry S; Dixon R; Gottlieb R; Kukrika M; Lipton A; Mortel R; Ricci J; White D
Cancer Treat Rep; 1979 Feb; 63(2):307-9. PubMed ID: 109201
[TBL] [Abstract][Full Text] [Related]
13. cis-Dichlorodiammineplatinum(II) in childhood cancer.
Freeman AI; Ettinger LJ; Brecher ML
Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
Wiltshaw E; Kroner T
Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.
Bruckner HW; Cohen CJ; Wallach RC; Kabakow B; Deppe G; Greenspan EM; Gusberg SB; Holland JF
Cancer Treat Rep; 1978 Apr; 62(4):555-8. PubMed ID: 350392
[TBL] [Abstract][Full Text] [Related]
16. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.
Yagoda A
Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226
[TBL] [Abstract][Full Text] [Related]
17. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
Vietti TJ; Nitschke R; Starling KA; van Eys J
Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
Alberts DS; Hilgers RD; Moon TE; Martimbeau PW; Rivkin S
Cancer Treat Rep; 1979 Feb; 63(2):301-5. PubMed ID: 109200
[TBL] [Abstract][Full Text] [Related]
20. Single-agent cis-platinum therapy for advanced ovarian cancer.
Gershenson DM; Wharton JT; Herson J; Edwards CL; Rutledge FN
Obstet Gynecol; 1981 Oct; 58(4):487-96. PubMed ID: 7024883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
